17-80192527-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001366385.1(CARD14):​c.1264G>A​(p.Glu422Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0287 in 1,613,618 control chromosomes in the GnomAD database, including 763 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E422D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.022 ( 58 hom., cov: 33)
Exomes 𝑓: 0.029 ( 705 hom. )

Consequence

CARD14
NM_001366385.1 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.19

Publications

11 publications found
Variant links:
Genes affected
CARD14 (HGNC:16446): (caspase recruitment domain family member 14) This gene encodes a caspase recruitment domain-containing protein that is a member of the membrane-associated guanylate kinase (MAGUK) family of proteins. Members of this protein family are scaffold proteins that are involved in a diverse array of cellular processes including cellular adhesion, signal transduction and cell polarity control. This protein has been shown to specifically interact with BCL10, a protein known to function as a positive regulator of cell apoptosis and NF-kappaB activation. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012]
CARD14 Gene-Disease associations (from GenCC):
  • familial pityriasis rubra pilaris
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
  • psoriasis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0033420026).
BP6
Variant 17-80192527-G-A is Benign according to our data. Variant chr17-80192527-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 458085.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0531 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CARD14NM_001366385.1 linkc.1264G>A p.Glu422Lys missense_variant Exon 12 of 24 ENST00000648509.2 NP_001353314.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CARD14ENST00000648509.2 linkc.1264G>A p.Glu422Lys missense_variant Exon 12 of 24 NM_001366385.1 ENSP00000498071.1 Q9BXL6-1

Frequencies

GnomAD3 genomes
AF:
0.0216
AC:
3289
AN:
152210
Hom.:
58
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00610
Gnomad AMI
AF:
0.0417
Gnomad AMR
AF:
0.0184
Gnomad ASJ
AF:
0.0375
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00683
Gnomad FIN
AF:
0.0218
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.0329
Gnomad OTH
AF:
0.0268
GnomAD2 exomes
AF:
0.0228
AC:
5728
AN:
250914
AF XY:
0.0234
show subpopulations
Gnomad AFR exome
AF:
0.00532
Gnomad AMR exome
AF:
0.0180
Gnomad ASJ exome
AF:
0.0317
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0212
Gnomad NFE exome
AF:
0.0333
Gnomad OTH exome
AF:
0.0343
GnomAD4 exome
AF:
0.0294
AC:
43027
AN:
1461290
Hom.:
705
Cov.:
30
AF XY:
0.0294
AC XY:
21336
AN XY:
726938
show subpopulations
African (AFR)
AF:
0.00571
AC:
191
AN:
33474
American (AMR)
AF:
0.0188
AC:
842
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0325
AC:
849
AN:
26128
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.00859
AC:
741
AN:
86242
European-Finnish (FIN)
AF:
0.0218
AC:
1158
AN:
53158
Middle Eastern (MID)
AF:
0.0583
AC:
336
AN:
5768
European-Non Finnish (NFE)
AF:
0.0334
AC:
37182
AN:
1111728
Other (OTH)
AF:
0.0286
AC:
1727
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
1926
3853
5779
7706
9632
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1358
2716
4074
5432
6790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0216
AC:
3288
AN:
152328
Hom.:
58
Cov.:
33
AF XY:
0.0202
AC XY:
1502
AN XY:
74496
show subpopulations
African (AFR)
AF:
0.00608
AC:
253
AN:
41580
American (AMR)
AF:
0.0184
AC:
282
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0375
AC:
130
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5182
South Asian (SAS)
AF:
0.00684
AC:
33
AN:
4828
European-Finnish (FIN)
AF:
0.0218
AC:
232
AN:
10620
Middle Eastern (MID)
AF:
0.0952
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
0.0329
AC:
2235
AN:
68024
Other (OTH)
AF:
0.0265
AC:
56
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
166
332
498
664
830
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0299
Hom.:
240
Bravo
AF:
0.0216
TwinsUK
AF:
0.0332
AC:
123
ALSPAC
AF:
0.0348
AC:
134
ESP6500AA
AF:
0.00817
AC:
36
ESP6500EA
AF:
0.0292
AC:
251
ExAC
AF:
0.0228
AC:
2768
Asia WGS
AF:
0.00520
AC:
19
AN:
3478
EpiCase
AF:
0.0345
EpiControl
AF:
0.0359

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 09, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 32199921) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Pityriasis rubra pilaris;C1864497:Psoriasis 2 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
Jan 22, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.020
T;T;.;T
Eigen
Benign
-0.22
Eigen_PC
Benign
-0.34
FATHMM_MKL
Benign
0.21
N
LIST_S2
Benign
0.68
.;.;T;T
MetaRNN
Benign
0.0033
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.3
M;M;M;M
PhyloP100
2.2
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-1.1
.;.;.;N
REVEL
Benign
0.033
Sift
Benign
0.10
.;.;.;T
Sift4G
Benign
0.22
T;.;T;T
Polyphen
0.88
P;P;.;P
Vest4
0.12
MPC
0.31
ClinPred
0.0051
T
GERP RS
3.6
Varity_R
0.12
gMVP
0.25
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61751629; hg19: chr17-78166326; API